4
Changes in Ownership
Alkermes plc. Filed Acc 0001127602-25-002645
EVP R&D, Chief Medical Officer sold 100,918 shares at $32.05 ($3,234,382)
- EVP R&D, Chief Medical Officer acquired 97,632 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Hopkinson Craig C. · EVP R&D, Chief Medical Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-30 | Exercise or conversion : show line 1 in the form 10b5-1 | +29,156 | $20.03 | $583,995 | 76,732 | D |
| 2025-01-30 | Exercise or conversion : show line 2 in the form 10b5-1 | +26,589 | $19.34 | $514,231 | 103,321 | D |
| 2025-01-30 | Exercise or conversion : show line 3 in the form 10b5-1 | +23,542 | $24.59 | $578,898 | 126,863 | D |
| 2025-01-30 | Exercise or conversion : show line 4 in the form 10b5-1 | +18,345 | $26.82 | $492,013 | 145,208 | D |
| 2025-01-30 | Sale : show line 5 in the form 10b5-1 | −100,918 | $32.05 | $3,234,382 | 44,290 | D |
| Open-market sales · 100,918 sh · avg $32.05 · $3,234,382 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-30 | Exercise or conversion : show line 6 in the form 10b5-1 Employee Stock Option (Right to Buy) | −29,156 | 87,566 | D |
| 2025-01-30 | Exercise or conversion : show line 7 in the form 10b5-1 Employee Stock Option (Right to Buy) | −26,589 | 161,734 | D |
| 2025-01-30 | Exercise or conversion : show line 8 in the form 10b5-1 Employee Stock Option (Right to Buy) | −23,542 | 106,758 | D |
| 2025-01-30 | Exercise or conversion : show line 9 in the form 10b5-1 Employee Stock Option (Right to Buy) | −18,345 | 92,271 | D |
Loading xslF345X05/form4.xml…